Loading...
$221.4K
Awarded Sep 17, 2026
Competition
NOT COMPETED UNDER SAP
Offers
1
Set-Aside
None
Solicitation Type
Simplified Acquisition
Performance Timeline
Start
Sep 30, 2026
Recompete planning should begin soon.
Contract: 75F40126P00167
UEI
XTSXJHQTL917
Parent Company
MIMETAS B.V.
Capabilities & Certifications
Headquarters Location
Current Obligation
$221,398
Base + Exercised Options
$221,398
Total Ceiling Value
$221,398
Contract Type
FIRM FIXED PRICE
Description
EO 14398 - PURCHASE ORDER FOR DEVELOPMENT OF A BLOOD-BRAIN BARRIER FORMATION AND INTEGRITY MODEL FOR THE EVALUATION OF POTENTIAL DEVELOPMENTAL NEUROTOXICITY
NAICS
RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
PSC
GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH
Place of Performance
Congressional District: 06
Awarding Agency
Top-tier Agency
Food and Drug Administration
Sub-tier Agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier Agency
Food and Drug Administration
Sub-tier Agency
FDA OFFICE OF ACQ GRANT SVCS
Office